tel服务质量投诉热线:021-62961702
","layout_7":[{}],"space_4":0,"href_4":{"type":"link","value":"/","target":"_self"},"dataList_6":[{"navName":"首页"},{"children":[{"children":[{"navName":"企业介绍"},{"navName":"发展历程"},{"navName":"关于我们"}],"navName":"企业介绍"},{"navName":"发展历程"},{"navName":"关于我们"}],"navName":"公司概况"},{"navName":"我们的产品"},{"children":[{"navName":"最新动态"},{"navName":"企业新闻"},{"navName":"行业新闻"}],"navName":"新闻资讯"},{"children":[{"navName":"合作伙伴"},{"navName":"加入我们"}],"navName":"招商加盟"},{"children":[{"navName":"服务宗旨"},{"navName":"在线咨询"},{"children":[{"navName":"生活常识"},{"navName":"百度百科"}],"navName":"常见问题"},{"navName":"用户协议"}],"navName":"售后服务"},{"children":[{"navName":"在线留言"},{"navName":"联系我们"}],"navName":"联系我们"}],"setting_4":{},"layout_1":[{},{}],"menu_6":"","imgList_4":[{"fit":"contain","imageUrl":"portal-saas/new2022061719585846666/cms/image/b3b10677-52d0-4d68-90c1-d1ff418dd5cd.png","isLazy":true}],"html_11":"
\n 服务质量投诉热线:021-62961702\n \n \n
\n\n
\n \n 中文 | EN\n
","title_4":"图片名称","arrow_6":""}"/>

26

2022

-

06

国产CT内卷之战:联影、东软、明峰有哪些杀手锏?

6月29日,上交所网站信息显示,科创板拟上市公司明峰医疗审核状态变更为“已受理”。这家国产CT前三的企业,在成立11年后迎来了「最大变化」。


Author:

6月29日,上交所网站信息显示,科创板拟上市公司明峰医疗审核状态变更为“已受理”。这家国产CT前三的企业,在成立11年后迎来了「最大变化」。

 

明峰医疗招股书(申报稿)显示,明峰医疗本次拟发行股份不超过1.50亿股,不低于发行后总股本的10%,不高于发行后总股本的18.58%,本次发行均为新股,不安排股东公开发售股份,海通证券股份有限公司为其保荐机构。
 

本次募集资金用于项目及拟投入的募资金额为:高端医学影像装备产业化项目,募集资金投入金额约2.65亿元;研发中心建设项目,募集资金投入金额约1.59亿元;补充流动资金,募集资金投入金额2亿元。本次股票发行后拟在上交所科创板上市。

2


 (图源:明峰医疗招股书)

明峰医疗成立于2011年,是一家医学影像设备研发、生产、销售及技术服务的高新技术企业。 作为国内为数不多的能够生产高端 CT 和 PET/CT 的医疗器械企业之一,亦是成功研发 256 排超高端 CT 的少数国内企业之一,正在向 MRI、US、DR等其他医学影像设备延伸。
 
其中 CT 产品线主要包括 8排、16排、24排、48排、64排、256排、车载CT系列、方舟CT系列等,覆盖临床实用普及机型到超高端科研机型以及移动医疗设备。同时也是国内较早从事 PET/CT 产品研发设计并取得产品医疗器械注册许可证的少数企业之一。
 
根据招股书内容,明峰医疗中高端CT产品营收占比连续三年持上升状态。

关键词:

医疗审核状态变更
53287

\n","layout_1":[{}],"layout_2":[{},{}],"pageConfig_5":{"rolling":{"navigation":true,"scrollType":"horizontal","pagenation":true,"scrollTime":4,"autoScroll":true},"showJump":true,"pageType":"hidden","pcColumn":1,"marquee":{"navigation":true,"marqueeTime":4},"loopItem":".p_loopitem","pcRow":10,"moColumn":1,"datasourceid":"datasource2","elementid":5},"href_28":{"type":"none","value":"","target":""},"layout_3":[{}],"format_15":"yyyy","selectValue_24":"2","href_23":{"type":"none","value":"","target":""},"text_4":"相关新闻","richtext_25":"

It was reported on March 19 that CATL is considering a site selection for a US$5 billion battery factory, which will eventually employ as many as 10,000 workers.

\n\n

CATL executives reportedly flew to Mexico for a meeting earlier this month. CATL’s new North American plant will produce nickel-manganese-cobalt and lithium iron phosphate batteries to supply Tesla and other automakers, two people familiar with the matter said.

\n\n

However, Ningde Times has not responded to this news.

\n\n

It is worth noting that last month, Ningde Times said at the media communication meeting about going to the United States to build a factory:

\n\n

CATL has a lot of interaction with American customers, including both new forces and traditional car companies. The two sides jointly discussed various possible supply and cooperation plans, as well as the possibility of localized production, but the specific situation needs to consider worker training, The impact of factors such as efficiency and labor unions on quality and cost.

\n","richtext_27":"

reported,considering,selection

\n","format_30":"yyyy-MM-dd","layout_20":[{},{}],"time_30":"2021-09-14T16:00:00.000Z","page_5":{"size":6,"from":0,"totalCount":100},"text_28":"关键词:","layout_21":[{},{}],"layout_26":[{},{}],"layout_9":[{},{}],"text_23":"Author:","layout_29":[{},{}],"range_11":"-","range_15":"-","href_18":{"type":"none","value":"","target":""},"href_17":{"type":"none","value":"","target":""},"range_14":"-","href_13":{"type":"none","value":"","target":""},"time_15":"2021-09-15 00:00","time_14":"2021-09-15 00:00","time_11":"2021-09-15 00:00","href_31":{"type":"field","value":"_href","target":"_self"}}"/>